The chemokines: Their potential role in allergic inflammation

Clinical and Experimental Allergy

Volumn 26, Issue 9, 1996, Pages 1005-1019

  Teran, L M ^a,b   Davies, D E ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES;

ALLERGY; ASTHMA; ENDOTHELIUM; HUMAN; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029792718     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1996.tb00640.x     Document Type: Review

References (118)

1. Modi WS, Dean M, Seuanez H et al. Monocyte derived neutrophil chemotactic factor (MDNCF IL-8) resides in a gene cluster along with several other members of the platelet factor gene family. Hum Genet 1990; 84:185-7.
2. Irving SG, Zipfel PF, Balke J et al. Two inflammatory mediator cytokine genes are closely linked and variably amplified on chromosome 17. Nucleic Acid Res 1990; 18: 3261-70.
3. Keiner GS, Kennedy J, Bacon KB et al. Lymphotactin: a novel cytokine which represents a new class of chemokine. Science 1994; 266:1395-9.
4. Teran LM, Montefort S, Douglass J, Holgate ST. Neutrophil and eosinophil chemotaxis in asthma. Quart J Med 1994; 86: 761-9.
5. Miller MD, Krangel MS. Biology and biochemistry of the chemokines: a family of chemotactic and inflammatory cytokines. Crit Rev Immunol 1992; 12:17-46.
6. White MV, Yoshimura T, Hook W, Kaliner M, Leonard EJ. Neutrophil attractant activation protein 1 (NAP-1) causes human basophil histamine release. Immunol Lett 1989; 22: 151-4.
7. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. Neutrophil activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1463.
8. Schröder J, Gregory H, Young J, Christophers E. Neutrophil-activating proteins in psoriasis. J Invest Dermatol 1992; 98:241-7.
9. Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992; 12:159-64.
10. Miller EJ, Cohen AB, Nagao S et al. Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am Rev Respir Dis 1992; 146: 427-32.
11. Marini M, Vittori E, Hollemborg J, Mattoli S. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992; 89:1001-9.
12. Redington AE, Bradding P, Douglass JA et al. Bronchial epithelial cytokine production in asthmatics and non-asthmatics (Abstract). Thorax 1993; 48:1081.
13. Yousefi S, Haemman S, Weber M et al. IL-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J Immunol 1995; 154:5481-90.
14. Sim TC, Recce LM, Hilsmeier KA, Grant JA, Alam R. Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment. Am J Respir Crit Care Med 1995; 152:927-33.
15. Teran LM, Carroll MP, Frew AJ et al. Leukocyte recruitment following local endobronchial allergen challenge in asthma: its relationship to procedure and to airway interleukin-8 release. Am J Respir Crit Care Med 1995; in press.
16. Teran LM, Johnston SL, Shute JK, Church MK, Holgate ST. Increased levels of interleukin-8 in the nasal aspirates of children with virus-associated asthma (Abstract). J Allergy Clin Immunol 1994; 93:272.
17. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L. Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 1993; 91:1198-205.
18. Schröder J, Noso N, Sticherling M, Christophers E. Role of eosinophil-chemotactic CC chemokines in cutaneous inflammation. J Leukoc Biol 1996; 59:1-5.
19. Douglass JA, Dhami D, Gurr CE et al. Influence of interleukin-8 challenge in the nasal mucosa of atopic and non-atopic subjects. Am J Respir Crit Care Med 1994; 150: 323-7.
20. Shute JK, Lindley I, Peichi P et al. Mucosal IgA is an important moderator of eosinophil migratory responses to tissue derived chemoattractants. Int Arch Allergy Appl Immunol 1995; 107:428-9.
21. Anisowicz A, Bardwell L, Sager R. Constitutive overexpression of a growth-regulated gene in transformed Chinise hamster and human cells. Proc Natl Acad Sci USA 1987; 84:7188.
22. Richmond A, Balentien E, Thomas HG et al. Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, growth factor structurally related to β-thromoglobulin. EMBO J 1988; 7:2025-33.
23. Tekamp-Olson P, Gallegos C, Bauer D et al. Cloning and characterization of cDNAs for murine macrophage inflammatory protein 2 and its human homologs. J Exp Med 1990; 172:911.
24. Haskill S, Peace A, Morris J et al. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci USA 1990; 87:7732.
25. Sager R, Anisowicz A, Pike MC, Beckman P, Smith T. Structural, regulatory, and functional studies of the GRO gene and protein. Cytokines 1992; 4:96-116.
26. + ]i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/ interleukin-8, NAP-2, and gro/MGSA. J Leukoc Biol 1991; 50:279-86.
27. Hogan M, Sherry B, Ritchlin C et al. Differential expression of the small inducible cytokines groα and groβ by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine 1994; 6:61-9.
28. Walz A, Dewald B, von Tscharner V, Baggiolini M. Effects on the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peplide III. and platelet factor 4 on human neutrophils. J Exp Med 1989; 170:1745-50.
29. Walz A, Zwahlen R, Baggiolini M. Formation and biological properties of neutrophil activating peptide 2 (NAP-2). Adv Exp Med Biol 1991; 305:39-46.
30. Capron A, Joseph M, Ameisen JC, Capron M, Pancre V, Auriault C. Platelets as effectors in immune and hypersensitivity reactions. Int Arch Allergy Appl Immunol 1987; 82:307-12.
31. Gresele P, Ribaldi E, Grasselli S, Todisco T, Nenci CG. Evidence for platelet activation in allergic asthma In: Schmitz-Schumann M, Menz G, Page CP, eds. Platelets, PAF and asthma, agents and actions. Basel: Birkhauser-Verlag, 1987:119-28.
32. Walz A, Burgener R, Car B, Baggiolini M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med 1991; 174:1355-62.
33. Power CA, Furness RB, Brawand C, Wells TNC. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene 1995; 151: 333-4.
34. Colletti LM, Kunkel SE, Walz A et al. Chemokine expression during hepatic ischemia reperfusion-induced lung injury in the rat. The role of epithelial neutrophil activating protein. J Clin Invest 1995; 95:134-41.
35. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vaguri P, Farber JM. Human mig chemokine: biochemical and functional characterization. J Exp Med 1995; 182:1301-14.
36. Taub DD, Lloyd AR, Conlon K et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-14.
37. Schall TJ, Jongstra J, Dyer BJ et al. A human T-cell specific molecule is a member of a new gene family. J Immunol 1988; 141:1018-25.
38. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of memory phenotype by cytokine RANTES. Nature 1990; 347:669-71.
39. Kameyoshi Y, Dorschner A, Mallet AE Christophers E, Schröder J. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 1992; 176:587-92.
40. Rot A, Krieger M, Brunner T et al. RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 1992; 176:1489-95.
41. Rathanaswami P, Hachicha M, Sadick M, Schall TJ, MeColl SR. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 1993; 268:5834-9.
42. Sticherling M, Kupper M, Koltrowitz F et al. Detection of chemokine RANTES in cytokine-stimulated human dermal fibroblasts. J Invest Dermatol 1995; 105:585-91.
43. Devergne O, Marfaing Koka A, Schall TJ et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994; 179:1689-94.
44. Heeger P, Wolf G, Meyers C et al. Isolation and characterization of cDNA from renal tubular epithelium encoding murine Rantes. Kidney Int 1992; 41:220-5.
45. Marfaing-Koka A, Devergene O, Gorgone G et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995; 154:1870-8.
46. Stellato C, Beck LA, Gorgone GA et al. Expression of the chemokine RANTES by a human bronchial epithelial cell line: modulation by cytokines and glucocorticoids. J Immunol 1995; 155:410-8.
47. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150:3442-8.
48. Kapp A, Zeck Kapp G, Czech W, Schopf E. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 1994; 102:906-14.
49. Ebisawa M, Yamada T, Bickel C, Klunk D, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. III Effect of the chemokine RANTES. J Immunol 1994; 153:2153-60.
50. Bacon KB, Flores Romo L, Aubry JP, Wells TN, Power CA. Interleukin-8 and RANTES induce the adhesion of the human basophilic cell line KU-812 to human endothelial cell monolayers. Immunology 1994; 82:473-81.
51. Meurer R, Van Riper G, Feeney W et al. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J Exp Med 1993; 178:1913-21.
52. Beck LA, Schall TJ, Beall LD et al. Detection of the chemokine RANTES and activation of vascular endothelium in nasal polyps. J Allergy Clin Immunol 1994; 93:234.
53. Alam R, York J, Boyars M et al. The involvement of the chemokines in bronchial asthma. The detection of the mRNA for MCP-1, MCP-3, RANTES, MIP-1α and IL-8 in bronchoalveolar lavage cells, and the measurement of RANTES and MIP-1α in the lavage fluid (Abstract). J Allergy Clin Immunol 1994; 93:183.
54. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T cell, and macrophage recruitment. J Exp Med 1995; 181: 2153-9.
55. Teran LM, Carroll M, Bodey KM, Gratziou C, Frew AJ, Holgate ST. The chemokines RANTES and MIP-1α are released into asthmatic airways after segmental allergen challenge. Eur Respir J 1995; 8:168s.
56. Teran L, Johnston SL, Holgate ST. Immunoreactive RANTES and MIP-1a are increased in the nasal aspirates of children with virus-associated asthma. Am J Respir Crit Care Med 1995; 151:A385.
57. Chichara J, Yamada H, Takamura E, Yoshino K, Nakajima S. Possible presence of RANTES in tears of patients with allergic conjuctivitis. Int Arch Allergy Immunol 1995; 106: 428.
58. Kwon OJ, Jose OP, Robbins RA, Schall TJ et al. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol 1995; 12: 488-96.
59. Wang JH, Devalia JL, Xia CL, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14:27-35.
60. Schall TJ. Biology of the RANTES SIS cytokine family. Cytokine 1991; 3: 165-83.
61. Alum R, Forsythe PA, Stafford S, Let-Brown MA, Grant JA. Macrophage inflammatory protein-1α activates basophils and mast cells. J Exp Med 1992; 176:781-6.
62. Graham GJ, Wright EG, Hewick R et al. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Nature 1990; 344:442-5.
63. Lukacs NW, Strieter RM, Shaklee CL, Chensue SW, Kunkel SL. Macrophage inflammatory protein-1α influences recruitment in antigen-specific airway inflammation. Eur J Immunol 1995; 25:245-51.
64. Alam R, Forsythe P, Stafford S et al. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol 1994; 153:3155-9.
65. Matsushima K, Larsen CG, Du Bois GC, Oppenheim JJ. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocyte cell line. J Exp Med 1989; 169:1485-90.
66. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA. Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1995; 91:3652-6.
67. Noso N, Proost P, van Damme J, Schroder J. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994; 200:1470-6.
68. Opdenakker G, Froyen G, Fiten P, Proost P, van Damme J. Human monocyte chemotactic protein-3 (MCP-3): molecular cloning of the cDNA and comparison with other chemokines. Biochem Biophys Res Commun 1993; 191: 535-42.
69. van Damme J, Proost P, Lenaerts JP, Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992; 176: 59-65.
70. Dahinden CA, Geiser T, Brunner T et al. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994; 179: 751-6.
71. Humbert M, Ying S, Barkans J et al. Elevated gene expression of RANTES and monocyte chemotactic protein-3 (MCP-3) in bronchial biopsies from asthmatics (Abstract). Am J Respir Crit Care Med 1995; 151:698.
72. Sousa AR, Lane S, Nakhostee JA et al. Increased expression of the monocytc chemoattractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994; 10:142-7.
73. Jose PJ, Griffiths-Johnson PD, Collins DT et al. Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation. J Exp Med 1994; 179:881-7.
74. Griffiths Johnson DA, Collins PD, Rossi AG, Jose PJ, Williams TJ. The chemokine, eotaxin, activates guinea-pig eosinophils in vitro and causes their accumulation into the lung in vivo. Biochem Biophys Res Commun 1993; 197: 1167-72.
75. Jose PJ, Adcock IM, Griffiths-Johnson DA et al. Cloning of an eosinophil chemoattractant cytokine and increased mRNA in allergen-challenged guinea-pigs lungs. Biochem Biophys Res Commun 1995; 205:788-94.
76. Collins PD, Marleu S, Gritliths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995; 182:1169-74.
77. Rothenberg ME, Luster AD, Leder P. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc Natl Acad Sci USA 1996; 92:8960-4.
78. Ponath PD, Qin S, Ringier DJ et al. Cloning of the human eosinophil chemoattractant, eotaxin. J Clin Invest 1996; 97: 604-12.
79. Ahuja SK, Gao JL, Murphy PM. Chemokine receptors and molecular mimicry. Immunol Today 1994; 15:281-7.
80. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking and inflammation. 1995; 6:865-73.
81. Holmes WE, Lee J, Kuang W, Rice GC, Wood WI. Structure and functional expression of a human interleukin-8 receptor. Science 1991; 253:1278-80.
82. Murphy PM, Tiffany HL. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991; 253:1280-3.
83. Charo IF, Myers SJ, Herman A et al. Molecular cloning and functional expression of two monocytc chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails. Proc Natl Acad Sci USA 1994; 91:2752-6.
84. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995; 270:16491-4. (Correction: J Biol Chem 1995; 270:30235).
85. Van Riper G, Siciliano S, Fischer PA et al. Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med 1993; 177:851-6.
86. Gao JL, Kuhns DB, Tiffany HL et al. Structure and functional expression of the human macrophage inflammatory protein 1 alpha RANTES receptor. J Exp Med 1993; 177:1421-7.
87. Neote K, DiGregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 1993; 72: 415-25.
88. Nomura H, Nielsen BW, Matsushima K. Molecular cloning of cDNAs encoding a LD78 receptor and putative leukocyte chemotactic peptide receptors. Int Immunol 1993; 5:1239-49.
89. Combadiere C, Ahuja SK, Van Dame J et al. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B. J Biol Chem 1995; 270:29671-5.
90. Power CA, Meyer A, Nemeth K et al. Molecular cloning and functional expression of a novel CC chemokine receptor cDNA from a human basophilic cell line. J Biol Chem 1995; 270:19495-500.
91. Power CA, Clemetson JM, Clemetson KJ, Well TNC. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 1995; 7:479-82.
92. Neote K, Mak JY, Kolakowski LL Jr, Schall TJ. Functional and biochemical analysis of the cloned Duffy antigen: identity with the red blood cell chemokine receptor. Blood 1994; 84:44-52.
93. Horuk R, Chitnis CE, Darbonne WC et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993; 261:1182-4.
94. Neote K, Darbonne W, Ogez J, Horuk R, Schall TJ. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells. J Biol Chem 1993; 268:12247-9.
95. Hadley TJ, Lu Z, Wasniowska K et al. Postcapillary ventile endothelial cells in kidney express a multispecific chemokine receptor that is structurally and functionally identical to the erythroid isoform, which is the duffy blood group antigen. J Clin Invest 1995; 94:985-91.
96. Bischoff SC, Krieger M, Brunner T et al. RANTES and related chemokines activate human basophil gianulocytes through different G protein-coupled receptors. Eur J Immunol 1993; 23:761-7.
97. Van Riper G, Nicholson DW, Scheid MP et al. Induction, characterization, and functional coupling of the high affinity chemokine receptor for RANTES and macrophage inflammatory protein-1 alpha upon differentiation of an eosinophilic HL-60 cell line. J Immunol 1994; 152:4055-61.
98. Hogg N. Roll, roll, roll your leukocyte gently down the vein. Immunol Today 1992: 13:113-5.
99. Detmers PA, Powell DE, Walz A et al. Differential effects of neutrophil-activating peptide 1 IL- 8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 1991; 147: 4211-7.
100. Detmers PA, Lo SK, Olsen Egbert E et al. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/ CD18 on human neutrophils. J Exp Med 1990; 171:1155-62.
101. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin 8. Science 1991; 254:99-102.
102. Jiang Y, Beller DI, Fredl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992; 148:2423-8.
103. Shyy JJ, Wickham LL, Hagan JP et al. Human monocyte colony-stimulating factor stimulates the gene expression of monocyte chemotactic protein-1 and increases the adhesion of monocytes to endothelial monolayares. J Clin Invest 1993; 92:1745-51.
104. Vaddi K, Newton RC. Regulation of monocyte integrin expression by β-family chemokines. J Immunol 1994; 153:4721-32.
105. + T cells in response to MIP-1α and MIP-1β. Science 1993; 260:355-8.
106. Rot A. Neutrophil attractant activation protein-1 (interleukin-8) induces in vitro migration by haptotactic mechanism. Eur J Immunol 1993; 23:303-6.
107. Tanaka Y, Adams DH, Hubscher S et al. T-cell adhesion induced by proteoglycan-immobolized cytokine MIP-1β Nature 1993; 361:79-82.
108. + T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. J Immunol 1994; 153:4899-906.
109. Schwartz D, Andalibi A, Chaverri-Almanda L et al. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium. J Clin Invest 1994; 94:1968-73.
110. Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995; 182:219-31.
111. Rot A. Binding of neutrophil attractant activation protein-1 (interleukin-8) to resident dermal cells. Cytokine 1992; 4: 347-52.
112. Rot A, Hub E. Leukocyte migration to RANTES. In: Krenski AM, ed. Biology of the chemokine RANTES. RG Landes Co., 1995:35-54.
113. Webb LM, Ehrengruber MU, Clark Lewis I, Baggiolini M, Rot A. Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8. Proc Natl Acad Sci USA 1993; 90:7158-62.
114. Hara T, Bacon KB, Cho LC et al. Molecular cloning and functional characterization of a novel member of the C-C chemokine family. J Immunol 1995; 155: 5352-8.
115. Schulz-Knappe P, Magert H, Dewald B et al. HCC-1, a novel chemokine from human plasma. J Exp Med 1996; 183:295-9.
116. Texeira MM, Williams TJ, Hellewell PG. Mechanisms and pharmacological manipulation of eosinophil accumulation in vivo. Trends Pharmacol Sci 1996; 16:418-23.
117. Shute JK. Interleukin 8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994; 24:203-6.
118. Samson M, Labbe O, Mollereu C, Vassart G, Parmentier M. Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochem 1996; 35:3362-7.